Mxene sorbent for removal of small molecules from dialysate
The present disclosure is directed to methods for scrubbing low levels of urea from aqueous solutions such as a dialysate from dialysis, and including blood and blood products, and devices capable of employing these methods.
1. A method of removing urea from an initial aqueous solution of urea, the method comprising subjecting the aqueous solution of urea to a MXene composition, at ambient or near ambient temperatures and under conditions, so that the urea is reduced from an initial concentration in the initial solution to a final concentration in a final solution, wherein the initial concentration of urea in the initial aqueous solution is in a range of from 10 mmol/L to 1000 mmol/L, or is initially in a concentration range from 15 to 40 mg/dL, and the final concentration is at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, or 90% less than the initial concentration, and
wherein the aqueous solution is or comprises blood or a blood product and the ambient or near ambient temperatures and conditions used do not compromise the utility of the blood or blood product for later use by a human patient.
2. The method of claim 1 , wherein the MXene composition comprises a composition comprising at least one layer having first and second surfaces, each layer described by a formula M n+1 X n T x and comprising:
substantially two-dimensional array of crystal cells, each crystal cell having an empirical formula of M n+1 X n , such that
each X is positioned within an octahedral array of M, wherein
M is at least one Group IIIB, IVB, VB, or VIB metal, wherein
each X is C, N, or a combination thereof;
n=1, 2, or 3; and wherein
T x represents surface termination groups.
3. The method of claim 2 , wherein at least one of said surfaces of each layer has surface termination groups (T x ) comprising alkoxide, carboxylate, halide, hydroxide, hydride, oxide, sub-oxide, nitride, sub-nitride, sulfide, thiol, or a combination thereof.
4. The method of claim 2 , wherein M is at least one Group IVB, Group VB, or Group VIB metal.
5. The method of claim 2 , wherein M is Ti, Mo, Nb, V, or Ta, or a combination thereof.
6. The method of claim 2 , wherein M n+1 X n is Ti 2 C, Mo 2 TiC 2 , Ti 3 C 2 , or a combination thereof.
7. The method of claim 1 , wherein the MXene composition comprises a composition comprising at least one layer having first and second surfaces, each layer comprising:
a substantially two-dimensional array of crystal cells,
each crystal cell having an empirical formula of M′ 2 M″ n X n+i , such that each X is positioned within an octahedral array of M′ and M″, and where M″ n are present as individual two-dimensional array of atoms intercalated between a pair of two-dimensional arrays of M′ atoms,
wherein M′ and M″ are different Group IIIB, IVB, VB, or VIB metals,
wherein each X is C, N, or a combination thereof; and
n=1 or 2.
8. The method of claim 7 , wherein n is 1, M′ is Mo, and M″ is Nb, Ta, Ti, or V, or a combination thereof.
9. The method of claim 7 , wherein n is 2, M′ is Mo, Ti, V, or a combination thereof, and M″ is Cr, Nb, Ta, Ti, or V, or a combination thereof.
10. The method of claim 7 , wherein M′ 2 M″ n X n+1 comprises Mo 2 TiC 2 , Mo 2 VC 2 , Mo 2 TaC 2 , Mo 2 NbC 2 , Mo 2 Ti 2 C 3 , Cr 2 TiC 2 , Cr 2 VC 2 , Cr 2 TaC 2 , Cr 2 NbC 2 , Ti 2 NbC 2 , Ti 2 TaC 2 , V 2 TaC 2 , Mo 2 Ti 2 C 3 , Mo 2 V 2 C 3 , Mo 2 Nb 2 C 3 , Mo 2 Ta 2 C 3 , Cr 2 Ti 2 C 3 , Cr 2 V 2 C 3 , Cr 2 Nb 2 C 3 , Cr 2 Ta 2 C 3 , Nb 2 Ta 2 C 3 , Ti 2 Nb 2 C 3 , Ti 2 Ta 2 C 3 , V 2 Ta 2 C 3 , V 2 Nb 2 C 3 , or V 2 Ti 2 C 3 , or a nitride or carbonitride analog thereof.
11. The method of claim 7 , wherein the MXene composition comprises a plurality of stacked layers.
12. The method of claim 7 , wherein at least one of said surfaces of each layer has surface terminations comprising alkoxide, carboxylate, halide, hydroxide, hydride, oxide, sub-oxide, nitride, sub-nitride, sulfide, thiol, or a combination thereof.
13. The method of claim 1 , wherein the aqueous solution further comprises amino acids, polypeptides, or blood plasma proteins.
14. The method of claim 1 , wherein the aqueous solution further comprises one or more of erythrocytes, leukocytes, or thrombocytes.
15. The method of claim 1 , wherein the aqueous solution further comprises one or more of such as glucose, fatty acids, and lactic acid.
16. The method of claim 1 , wherein the initial concentration is a physiologically relevant concentration to a human patient.
17. The method of claim 1 , wherein the final aqueous solution of urea is contacted with previously unexposed MXene compositions.
18. The method of claim 1 , final aqueous solution of urea is contacted with previously unexposed MXene compositions more than once in a recycle scenario.
19. The method of claim 1 , wherein the urea is undetectable in the final solution by 1 H NMR.